Uncategorized
Anti-VEGF with targeted retinal photocoagulation does not reduce treatment burden for DME patients
MIAMI — Anti-VEGF injections in combination with targeted retinal photocoagulation did not show a decrease in treatment burden in patients with diabetic macular edema in the DAVE trial, according to a presenter here. “While targeted laser did not seem to hinder either the anatomic or visual acuity results, to date, we have no evidence that [suggests] targeted retinal photocoagulation reduces treatment for diabetic macular edema,” David M. Brown, MD, FACS, said at Angiogenesis, Exudation, and Degeneration 2016.